joins
In the past couple of months, the healthcare and pharmaceutical sectors have undergone significant regulatory and policy shifts, highlighting a sustained focus on transparency, quality assurance, and ...
“In the past couple of months, the healthcare and pharmaceutical sectors have undergone a series of structural reforms and policy adjustments, highlighting a clear focus on enhancing patient-centricity, standardising quality benchmarks, and streamlining regulatory compliance.
In this regard, a significant development has been the introduction of a new classification framework for mental health establishments by the Central Mental Health Authority, a step intended to bring uniformity and strengthen regulatory oversight. Complementing this focus on healthcare access, the Goods and Services Tax Council announced a significant rationalisation of tax rates for essential medicines and medical devices, aiming to reduce healthcare costs and improve affordability for patients. On the industry front, the Department of Pharmaceuticals has amended the Uniform Code for Pharmaceutical Marketing Practices, 2024, signalling a shift towards a self-regulatory model designed to ease compliance while ensuring ethical marketing.
These developments collectively reflect a strategic push towards building a more robust, transparent, and accessible healthcare ecosystem in India.
“In this edition of ‘Checking the Pulse’, CMS INDUSLAW’s Shantanu Jindel, Shweta Gupta, Kanika Sachdeva, Samarth Jain and Suryanshu Mishra delve into key regulatory updates from August 2025 to September 2025 in the healthcare and pharmaceutical sectors.”
